IMP3 accelerates the progression of prostate cancer through inhibiting PTEN expression in a SMURF1-dependent way
- Type
- Retraction
- Notice date
- 1/17/2023 0:00
- Journal
- Journal of Experimental & Clinical Cancer Research: (CR)
- Publisher
- Springer - Biomed Central (BMC)
- Notice DOI
- 10.1186/s13046-023-02599-z
- Original paper DOI
- 10.1186/s13046-020-01657-0